Welcome to LookChem.com Sign In|Join Free

CAS

  • or

143388-64-1

Post Buying Request

143388-64-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

143388-64-1 Usage

Description

Naramig was launched in Germany, Sweden and the UK for use in migraine. It is chemically available via a number of related synthetic routes all having about three steps starting from 5-bromoindole. It is a new serotonin 5-HT1B/1D receptor antagonist with modest affinity for 5-HT1a, and very weak affinity for 5-HT3 receptors. It has little or no affinity for a wide range of non-serotonin receptors including a- and padrenoceptors, dopamine, neurokinin NK1, and opiate receptors. It mediates vasoconstriction in cerebral vasculature (extra cerebral intracranial vessels), reduces neurogenic inflammation, and inhibits responses mediated by the trigeminal nerves. It has a 6- and 3-fold greater affinity for 5-HT1B, and 5-HT1D, receptors, respectively, than sumatriptan which translates to a 2-3 fold increase in potency. The reoccurance of headache was less compared to sumatriptan, zolmitriptan and rizatriptan. Naramig had no clinical effects on blood pressure or heart rate, had a long duration of action with very good tolerability, and has high oral bioavailability.

Chemical Properties

Beige Solid

Uses

Different sources of media describe the Uses of 143388-64-1 differently. You can refer to the following data:
1. Naratriptan Hydrochloride is a triptan drug and is used for the treatment of migraine headaches
2. Naratriptan Hydrochloride is a triptan drug that is used for the treatment of migraine headaches. It is a selective 5-hydroxytryptamine1 receptor subtype agonist
3. laxative

Check Digit Verification of cas no

The CAS Registry Mumber 143388-64-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,3,8 and 8 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 143388-64:
(8*1)+(7*4)+(6*3)+(5*3)+(4*8)+(3*8)+(2*6)+(1*4)=141
141 % 10 = 1
So 143388-64-1 is a valid CAS Registry Number.
InChI:InChI=1/C17H25N3O2S.ClH/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14;/h3-4,11-12,14,18-19H,5-10H2,1-2H3;1H

143388-64-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1457469)  Naratriptan hydrochloride  United States Pharmacopeia (USP) Reference Standard

  • 143388-64-1

  • 1457469-125MG

  • 6,177.60CNY

  • Detail
  • Sigma

  • (N1415)  Naratriptan hydrochloride  ≥98% (HPLC)

  • 143388-64-1

  • N1415-10MG

  • 700.83CNY

  • Detail
  • Sigma

  • (N1415)  Naratriptan hydrochloride  ≥98% (HPLC)

  • 143388-64-1

  • N1415-50MG

  • 2,776.41CNY

  • Detail

143388-64-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Naratriptan hydrochloride

1.2 Other means of identification

Product number -
Other names Amerge GR-85548A N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:143388-64-1 SDS

143388-64-1Synthetic route

naratriptan
121679-13-8

naratriptan

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In ethanol at 0 - 30℃; for 1h; pH=1.0 - 1.5; Product distribution / selectivity;93.4%
With hydrogenchloride In methanol; water at 0 - 10℃;84%
With hydrogenchloride In methanol; ethanol at 5 - 25℃; pH=1.0;71.7%
With hydrogenchloride In isopropyl alcohol; acetone at 5 - 10℃; pH=1;
palladium oxide on charcoal

palladium oxide on charcoal

N-methyl-2-[3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-1H-indol-5-yl]ethenesulphonamide
166306-28-1

N-methyl-2-[3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-1H-indol-5-yl]ethenesulphonamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
In hydrogenchloride; methanesulfonic acid; water88%
With hydrogenchloride In water; ethyl acetate; N,N-dimethyl-formamide
With hydrogenchloride In water; ethyl acetate; N,N-dimethyl-formamide
N-methyl-2-[3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-5-yl]ethanesulfonamide
121679-20-7

N-methyl-2-[3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-5-yl]ethanesulfonamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Stage #1: N-methyl-2-[3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-5-yl]ethanesulfonamide With hydrogen; acetic acid; platinum(IV) oxide In methanol at 50 - 60℃; under 3677.86 Torr;
Stage #2: With hydrogenchloride In ethanol; isopropyl alcohol for 1h; Product distribution / selectivity; Reflux;
85%
Multi-step reaction with 2 steps
1.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
1.2: 10 °C / pH 7.5 - 8.5
2.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
palladium oxide on charcoal

palladium oxide on charcoal

(E)-N-Methyl-2-[3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-1H-indol-5-yl]ethene sulphonamide, hydrochloride
166306-29-2

(E)-N-Methyl-2-[3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-1H-indol-5-yl]ethene sulphonamide, hydrochloride

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
In methanol; water; ethyl acetate; N,N-dimethyl-formamide71.2%
C18H24N3O4S(1-)*Na(1+)

C18H24N3O4S(1-)*Na(1+)

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In water for 12h; pH=2; Product distribution / selectivity; Heating / reflux;
palladium oxide on charcoal

palladium oxide on charcoal

N-methyl-2-[3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-1H-indol-5-yl]ethenesulphonamide
166306-28-1

N-methyl-2-[3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-1H-indol-5-yl]ethenesulphonamide

pyrographite
7440-44-0

pyrographite

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In ethyl acetate; N,N-dimethyl-formamide
With hydrogenchloride In ethyl acetate; N,N-dimethyl-formamide
2-(4-amino-phenyl)ethanesulfonic acid methylamide
98623-16-6

2-(4-amino-phenyl)ethanesulfonic acid methylamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: sodium hydrogencarbonate; iodine / dichloromethane / 25 - 30 °C
2.1: dichloromethane / 1.5 h / 25 °C
3.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
3.2: 25 °C
4.1: potassium hydroxide; ethanol / 15 - 25 °C
5.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
5.2: 0.5 h / 25 °C
6.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
6.2: 10 - 15 °C / pH 8
7.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
7.2: 10 °C / pH 7.5 - 8.5
8.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 7 steps
1.1: sodium hydrogencarbonate; iodine / dichloromethane / 25 - 30 °C
2.1: dichloromethane / 1.5 h / 25 °C
3.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
3.2: 25 °C
4.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 25 - 85 °C / Inert atmosphere
4.2: 0.5 h / 25 °C
5.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
5.2: 10 - 15 °C / pH 8
6.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
6.2: 10 °C / pH 7.5 - 8.5
7.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 8 steps
1.1: sodium hydrogencarbonate; iodine / dichloromethane / 25 - 30 °C
2.1: methanol / 25 - 30 °C
2.2: 4 h / 25 - 30 °C
3.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
3.2: 25 °C
4.1: potassium hydroxide; ethanol / 15 - 25 °C
5.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
6.1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
7.1: hydrogen; ethanol; triethylsilane / palladium 10% on activated carbon / ethanol / 25 - 30 °C
8.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 9 steps
1.1: sodium hydrogencarbonate; iodine / dichloromethane / 25 - 30 °C
2.1: methanol / 25 - 30 °C
2.2: 4 h / 25 - 30 °C
3.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
3.2: 25 °C
4.1: potassium hydroxide; ethanol / 15 - 25 °C
5.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
6.1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
7.1: trifluoroacetic acid / dichloromethane / 0.17 h / 25 °C
7.2: 25 - 30 °C
7.3: 10 - 15 °C
8.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 724.03 Torr
8.2: 10 °C / pH 7.5 - 8.5
9.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
N-Methyl-1H-indole-5-ethanesulphonamide
98623-50-8

N-Methyl-1H-indole-5-ethanesulphonamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
1.2: 10 - 15 °C / pH 8
2.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
2.2: 10 °C / pH 7.5 - 8.5
3.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
N-[2-iodo-4-(2-(methylsulfamoyl)ethyl)phenyl]acetamide
1268265-90-2

N-[2-iodo-4-(2-(methylsulfamoyl)ethyl)phenyl]acetamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
1.2: 25 °C
2.1: potassium hydroxide; ethanol / 15 - 25 °C
3.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
3.2: 0.5 h / 25 °C
4.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
4.2: 10 - 15 °C / pH 8
5.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
5.2: 10 °C / pH 7.5 - 8.5
6.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 5 steps
1.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
1.2: 25 °C
2.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 25 - 85 °C / Inert atmosphere
2.2: 0.5 h / 25 °C
3.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
3.2: 10 - 15 °C / pH 8
4.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
4.2: 10 °C / pH 7.5 - 8.5
5.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
2-(4-benzylamino-3-iodophenyl)ethanesulfonic acid methylamide
1268265-93-5

2-(4-benzylamino-3-iodophenyl)ethanesulfonic acid methylamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
1.2: 25 °C
2.1: potassium hydroxide; ethanol / 15 - 25 °C
3.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
4.1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
5.1: trifluoroacetic acid / dichloromethane / 0.17 h / 25 °C
5.2: 25 - 30 °C
5.3: 10 - 15 °C
6.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 724.03 Torr
6.2: 10 °C / pH 7.5 - 8.5
7.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 6 steps
1.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
1.2: 25 °C
2.1: potassium hydroxide; ethanol / 15 - 25 °C
3.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
4.1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
5.1: hydrogen; ethanol; triethylsilane / palladium 10% on activated carbon / ethanol / 25 - 30 °C
6.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
N-[4-(2-{methylsulfamoyl}ethyl)-2-{2-(trimethylsilanyl)ethynyl}phenyl]acetamide
1268265-95-7

N-[4-(2-{methylsulfamoyl}ethyl)-2-{2-(trimethylsilanyl)ethynyl}phenyl]acetamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: potassium hydroxide; ethanol / 15 - 25 °C
2.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
2.2: 0.5 h / 25 °C
3.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
3.2: 10 - 15 °C / pH 8
4.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
4.2: 10 °C / pH 7.5 - 8.5
5.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 4 steps
1.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 25 - 85 °C / Inert atmosphere
1.2: 0.5 h / 25 °C
2.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
2.2: 10 - 15 °C / pH 8
3.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
3.2: 10 °C / pH 7.5 - 8.5
4.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
2-(4-benzylamino-3-trimethylsilanylethynyl-phenyl)ethanesulfonic acid methylamide
1268265-97-9

2-(4-benzylamino-3-trimethylsilanylethynyl-phenyl)ethanesulfonic acid methylamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: potassium hydroxide; ethanol / 15 - 25 °C
2.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
3.1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
4.1: trifluoroacetic acid / dichloromethane / 0.17 h / 25 °C
4.2: 25 - 30 °C
4.3: 10 - 15 °C
5.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 724.03 Torr
5.2: 10 °C / pH 7.5 - 8.5
6.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 5 steps
1: potassium hydroxide; ethanol / 15 - 25 °C
2: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
3: potassium hydroxide / methanol / 8 h / 60 - 65 °C
4: hydrogen; ethanol; triethylsilane / palladium 10% on activated carbon / ethanol / 25 - 30 °C
5: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
N-[2-ethynyl-4-(2-(methylsulfamoyl)ethyl)phenyl]acetamide
1268265-99-1

N-[2-ethynyl-4-(2-(methylsulfamoyl)ethyl)phenyl]acetamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
1.2: 0.5 h / 25 °C
2.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
2.2: 10 - 15 °C / pH 8
3.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
3.2: 10 °C / pH 7.5 - 8.5
4.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
2-(4-benzylamino-3-ethynylphenyl)ethanesulfonic acid methylamide
1268266-01-8

2-(4-benzylamino-3-ethynylphenyl)ethanesulfonic acid methylamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
2.1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
3.1: trifluoroacetic acid / dichloromethane / 0.17 h / 25 °C
3.2: 25 - 30 °C
3.3: 10 - 15 °C
4.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 724.03 Torr
4.2: 10 °C / pH 7.5 - 8.5
5.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 4 steps
1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
2: potassium hydroxide / methanol / 8 h / 60 - 65 °C
3: hydrogen; ethanol; triethylsilane / palladium 10% on activated carbon / ethanol / 25 - 30 °C
4: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
2-(1-benzyl-1H-indol-5-yl)ethanesulfonic acid methylamide
894351-85-0

2-(1-benzyl-1H-indol-5-yl)ethanesulfonic acid methylamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
2.1: trifluoroacetic acid / dichloromethane / 0.17 h / 25 °C
2.2: 25 - 30 °C
2.3: 10 - 15 °C
3.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 724.03 Torr
3.2: 10 °C / pH 7.5 - 8.5
4.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 3 steps
1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
2: hydrogen; ethanol; triethylsilane / palladium 10% on activated carbon / ethanol / 25 - 30 °C
3: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
2-[1-benzyl-3-(1-methyl-1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indol-5-yl]-ethanesulfonic acid methylamide
894351-86-1

2-[1-benzyl-3-(1-methyl-1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indol-5-yl]-ethanesulfonic acid methylamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: trifluoroacetic acid / dichloromethane / 0.17 h / 25 °C
1.2: 25 - 30 °C
1.3: 10 - 15 °C
2.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 724.03 Torr
2.2: 10 °C / pH 7.5 - 8.5
3.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
N-methyl-2-[1-benzyl-3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide
894351-87-2

N-methyl-2-[1-benzyl-3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 724.03 Torr
1.2: 10 °C / pH 7.5 - 8.5
2.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
2-(4-amino-3-iodo-phenyl)ethanesulfonic acid methylamide
1200070-42-3

2-(4-amino-3-iodo-phenyl)ethanesulfonic acid methylamide

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: dichloromethane / 1.5 h / 25 °C
2.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
2.2: 25 °C
3.1: potassium hydroxide; ethanol / 15 - 25 °C
4.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
4.2: 0.5 h / 25 °C
5.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
5.2: 10 - 15 °C / pH 8
6.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
6.2: 10 °C / pH 7.5 - 8.5
7.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 6 steps
1.1: dichloromethane / 1.5 h / 25 °C
2.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
2.2: 25 °C
3.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 25 - 85 °C / Inert atmosphere
3.2: 0.5 h / 25 °C
4.1: trifluoroacetic acid / ethanol / 25 °C / Reflux
4.2: 10 - 15 °C / pH 8
5.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 1448.05 - 2172.08 Torr
5.2: 10 °C / pH 7.5 - 8.5
6.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 7 steps
1.1: methanol / 25 - 30 °C
1.2: 4 h / 25 - 30 °C
2.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
2.2: 25 °C
3.1: potassium hydroxide; ethanol / 15 - 25 °C
4.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
5.1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
6.1: hydrogen; ethanol; triethylsilane / palladium 10% on activated carbon / ethanol / 25 - 30 °C
7.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
Multi-step reaction with 8 steps
1.1: methanol / 25 - 30 °C
1.2: 4 h / 25 - 30 °C
2.1: copper(l) iodide; lithium chloride / N,N-dimethyl-formamide / 0.5 h / 25 °C
2.2: 25 °C
3.1: potassium hydroxide; ethanol / 15 - 25 °C
4.1: potassium tert-butylate / 1-methyl-pyrrolidin-2-one / 80 - 85 °C
5.1: potassium hydroxide / methanol / 8 h / 60 - 65 °C
6.1: trifluoroacetic acid / dichloromethane / 0.17 h / 25 °C
6.2: 25 - 30 °C
6.3: 10 - 15 °C
7.1: hydrogen; acetic acid / palladium 10% on activated carbon / 25 °C / 724.03 Torr
7.2: 10 °C / pH 7.5 - 8.5
8.1: hydrogenchloride / isopropyl alcohol; acetone / 5 - 10 °C / pH 1
View Scheme
naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

2-[4-formylamino-3-(1-methylpiperidine-4-carbonyl)phenyl]ethanesulphonic acid methylamide

2-[4-formylamino-3-(1-methylpiperidine-4-carbonyl)phenyl]ethanesulphonic acid methylamide

Conditions
ConditionsYield
With sodium periodate In methanol at 20℃; for 68.5h;76%
1-((4-azido)phenylthio)pyrrolidine-2,5-dione

1-((4-azido)phenylthio)pyrrolidine-2,5-dione

naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

2-(2-(4-azidophenyl)thio-3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)-N-methylethanesulfonamide

2-(2-(4-azidophenyl)thio-3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)-N-methylethanesulfonamide

Conditions
ConditionsYield
With 2-((-2-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)cyclohexyl)carbamoyl)-3,4,5,6-tetrachlorobenzoic acid; trifluoroacetic acid In methanol; dichloromethane; water at 20℃; for 24h;49%
naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

1-methyl-5'-(2-(N-methylsulfamoyl)ethyl)-2'-oxo-1-azaspiro[bicyclo[2.2.1]heptane-7,3'-indolin]-1-ium iodide

1-methyl-5'-(2-(N-methylsulfamoyl)ethyl)-2'-oxo-1-azaspiro[bicyclo[2.2.1]heptane-7,3'-indolin]-1-ium iodide

Conditions
ConditionsYield
With water; iodine; sodium hydrogencarbonate In tetrahydrofuran at 20℃; for 20h; chemoselective reaction;24%
naratriptan hydrochloride
143388-64-1

naratriptan hydrochloride

naratriptan
121679-13-8

naratriptan

Conditions
ConditionsYield
With sodium hydroxide In water

143388-64-1Downstream Products

143388-64-1Relevant articles and documents

A PROCESS FOR THE SYNTHESIS OF NARATRIPTAN

-

, (2011/04/13)

The present invention relates to a process for preparing naratriptan or a salt thereof, the process comprising: (a) reacting a compound of formula (3) with a compound of the formula HCCR wherein Z is a protecting group, Y is a leaving group and R is a trialkyl silyl group, a trialkylstannyl group or a zinc (II) halide, to obtain the compound of formula (4); (b) converting the compound of formula (4) to a compound of formula (5) wherein Z'' is hydrogen or a benzyl group; (c) converting the compound of formula (5) to naratriptan; and (d) optionally converting naratriptan to a salt thereof. The present invention also provides novel compounds (3) and (4) and processes for their preparation.

PROCESS FOR PREPARATION OF NARATRIPTAN HYDROCHLORIDE

-

Page/Page column 28, (2009/10/22)

The present invention relates to an improved process for the preparation of N-methyl-3- (1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide hydrochloride of formula (I) having less than 0.15 % area by HPLC of 3-(1-methyl-4-piperidinyl)-1H-indole-5- ethanesulfonamide (1A) and intermediates thereof.

PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES

-

Page/Page column 16-17, (2008/12/06)

The present invention relates to a novel process for the preparation of indole derivatives. In particular, present invention relates to the process for preparing naratriptan of formula (I), and its salts using novel intermediates. The present invention also relates to novel synthetic intermediates useful in the preparation of naratriptan hydrochloride.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 143388-64-1